Naiyana Praditsitthikorn BSc(Pharm), PhD*,** * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand ** Bureau of AIDS TB and STIs, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand There is an increasing number of at

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

Joshua R. Freeman, Ph.D., M.P.H., is a Researcher in the Research International Unit of the HITAP Foundation. He holds a Ph.D. in Epidemiology and an M.P.H. in Public Health. His research focuses on sleep health throughout the life course, investigating how sleep patterns and circadian rhythms influence health outcomes, and contributing to evidence

Chotika Suwanpanich is a researcher at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand. She holds a Doctor of Pharmacy degree from Silpakorn University and has knowledge and experience in health economics, economic evaluations, and impact assessments of health interventions.Chotika has worked o

Yot Teerawattananon is a Assistant Secretary General of the Foundation & Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines,

The Ministry of Health (MoH), Bhutan has developed a health technology assessment (HTA) program in Bhutan since 2013 and has continued its efforts to build HTA capacity and maintain its momentum. This year, the MoH shows interest and is seeking support on: • Cost-effectiveness threshold led by th

The International Decision Support Initiative (iDSI), a global network of priority setting institutions, has been providing guidance on Health Technology Assessment (HTA) in India since 2017, supported by the Bill and Melinda Gates Foundation (BMGF) India Office. The support on HTA institutionalisat

Over the past 5 years, together with colleagues from across the globe, we have helped empower policy-makers to make decisions that are evidence-based and procedurally fair, in order to improve the quality and efficiency of their health systems. This year has been a turning point for us. We